Fortress Biotech (FBIO) Amortizatization of Intangibles (2015 - 2025)
Fortress Biotech (FBIO) posted quarterly Amortizatization of Intangibles of $339000.0 for Q4 2025, up 13.0% year-over-year from $300000.0 in Q4 2024, and up 6.27% quarter-over-quarter from $319000.0 in Q3 2025.
Powered by 
Analysis
Fortress Biotech (FBIO) Amortizatization of Intangibles (2015 - 2025) Analysis & Trends
Fortress Biotech's Amortizatization of Intangibles history runs 11 years deep, the most recent figure standing at $339000.0 for Q4 2025.
- In Q4 2025, Amortizatization of Intangibles rose 13.0% year-over-year to $339000.0; the TTM figure through Dec 2025 stood at $1.4 million (down 31.65% YoY), while the FY2025 annual figure was $1.4 million, down 31.65% from the prior year.
- Amortizatization of Intangibles for Q4 2025 stood at $339000.0, up from $319000.0 in the prior quarter.
- The five-year high for Amortizatization of Intangibles was $2.3 million in Q4 2021, with the low at $100000.0 in Q3 2022.
- The 5-year median for Amortizatization of Intangibles is $479500.0 (2023), against an average of $581050.0.
- The sharpest annual moves came in 2021 and 2022: Amortizatization of Intangibles soared 656.11% in 2021, then tumbled 86.11% in 2022.
- Fortress Biotech's Amortizatization of Intangibles stood at $2.3 million in 2021, then tumbled by 75.34% to $565000.0 in 2022, then decreased by 10.09% to $508000.0 in 2023, then plunged by 40.94% to $300000.0 in 2024, then advanced by 13.0% to $339000.0 in 2025.
- Business Quant data shows FBIO's Amortizatization of Intangibles at $339000.0 in Q4 2025, $319000.0 in Q3 2025, and $451000.0 in Q2 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amort. of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 141.52 Bn | 133.66 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 86.69 Bn | 78.69 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.63 Bn | 59.45 Bn | 1.37 Bn | - |
| 4 | Moderna | 59.30 Bn | 54.16 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.41 Bn | 44.41 Bn | - | 4.33 Mn |
| 6 | BeOne Medicines | 40.45 Bn | 35.35 Bn | 1.53 Bn | - |
| 7 | Alnylam Pharmaceuticals | 35.29 Bn | 31.98 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.44 Bn | 27.60 Bn | - | - |
| 9 | Insmed | 27.55 Bn | 26.39 Bn | 358.27 Mn | 678,000.00 |
| 10 | Fortress Biotech | 86.15 Mn | -110.42 Mn | 12.58 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 476,000.00 |
| Sep 30, 2025 | 496,000.00 |
| Jun 30, 2025 | 486,000.00 |
| Mar 31, 2025 | 485,000.00 |
| Dec 31, 2024 | 480,000.00 |
| Sep 30, 2024 | 473,000.00 |
| Jun 30, 2024 | 1.28 Mn |
| Mar 31, 2024 | 609,000.00 |
| Dec 31, 2023 | 508,000.00 |
| Sep 30, 2023 | 657,000.00 |
| Jun 30, 2023 | 1.22 Mn |
| Mar 31, 2023 | 644,000.00 |
| Dec 31, 2022 | 565,000.00 |
| Sep 30, 2022 | 100,000.00 |
| Jun 30, 2022 | 506,000.00 |
| Mar 31, 2022 | 440,000.00 |
| Dec 31, 2021 | 2.29 Mn |
| Sep 30, 2021 | 720,000.00 |
| Jun 30, 2021 | 200,000.00 |
| Mar 31, 2021 | 415,000.00 |